ACTUATE THERAPEUTICS, INC.
ACTU · XNASCIK 1652935fmd_1NJPZARV55HS8XV9TF2V3BACCEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Jun 30, 2026, 14 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Research and development | 22 | 19 | 10 |
| Total operating expenses | 25 | 25 | 22 |
| Operating income | (25) | (25) | (22) |
| Interest expense | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | (2) | 0 |
| Income tax expense | 0 | 0 | 0 |
| Net income | (25) | (27) | (22) |